The rise and fall of NMDA antagonists for ischemic stroke.
It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show...
Main Authors: | Hoyte, L, Barber, P, Buchan, A, Hill, MD |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2004
|
פריטים דומים
-
NMDA antagonists: their role in neuroprotection.
מאת: Small, D, et al.
יצא לאור: (1997) -
NMDA antagonists: their role in neuroprotection.
מאת: Small, D, et al.
יצא לאור: (1997) -
Do NMDA antagonists prevent neuronal injury? No.
מאת: Buchan, A
יצא לאור: (1992) -
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
מאת: Buchan, A, et al.
יצא לאור: (1993) -
The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
מאת: Buchan, A, et al.
יצא לאור: (1992)